# PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

> **NCT02618850** · NA · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 260 (estimated)

## Conditions studied

- Colorectal Cancer Stage IV

## Interventions

- **PROCEDURE:** PET/CT
- **DRUG:** first-line chemotherapy

## Key facts

- **NCT ID:** NCT02618850
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618850, "PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02618850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*